Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
BMJ (Clinical Research Ed.)
|
May 27, 2025
A village doctor-led mobile health intervention for cardiovascular risk reduction in rural China: cluster randomised controlled trial
Xingyi Zhang, Siming Wang, Xingyu Zhou, et al.
American Journal of Hypertension
|
February 19, 2021
Rationale and Design of a Cluster Randomized Trial of a Village Doctor-Led Intervention on Hypertension Control in China
Yingxian Sun, Zhao Li, Xiaofan Guo, et al.
Lancet (London, England)
|
May 2, 2022
A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trial
Yingxian Sun, Jianjun Mu, Dao Wen Wang, et al.
Journal of the American College of Cardiology
|
July 8, 2026
Cardiovascular Health Change Patterns After Multifaceted Antihypertensive Intervention and Cardiovascular Outcomes: A Post Hoc Analysis of CRHCP Trial
Xiaofan Guo, Guozhe Sun, Ziyi Xie, et al.
Lancet (London, England)
|
March 5, 2023
Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial
Jiang He, Nanxiang Ouyang, Xiaofan Guo, et al.
Scientific Reports
|
May 19, 2016
VEGF-B inhibits hyperglycemia- and Macugen-induced retinal apoptosis
Delong Huang, Chen Zhao, Rong Ju, et al.
BMC Medicine
|
March 3, 2026
Cardiovascular outcomes of intensive blood pressure control in patients with and without metabolic dysfunction-associated fatty liver disease: post hoc analysis of the CRHCP trial
Songyue Liu, Yangzhi Yin, Hongmei Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 20, 2017
Critical role of caveolin-1 in ocular neovascularization and multitargeted antiangiogenic effects of cavtratin via JNK
Yida Jiang, Xianchai Lin, Zhongshu Tang, et al.
Oncotarget
|
October 28, 2016
PDGF-CC underlies resistance to VEGF-A inhibition and combinatorial targeting of both suppresses pathological angiogenesis more efficiently
Lei Zheng, Chen Zhao, Yuxiang Du, et al.
Signal Transduction and Targeted Therapy
|
August 17, 2023
VEGF-B prevents excessive angiogenesis by inhibiting FGF2/FGFR1 pathway
Chunsik Lee, Rongyuan Chen, Guangli Sun, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
BMJ (Clinical Research Ed.)
|
May 27, 2025
A village doctor-led mobile health intervention for cardiovascular risk reduction in rural China: cluster randomised controlled trial
Xingyi Zhang, Siming Wang, Xingyu Zhou, et al.
American Journal of Hypertension
|
February 19, 2021
Rationale and Design of a Cluster Randomized Trial of a Village Doctor-Led Intervention on Hypertension Control in China
Yingxian Sun, Zhao Li, Xiaofan Guo, et al.
Lancet (London, England)
|
May 2, 2022
A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trial
Yingxian Sun, Jianjun Mu, Dao Wen Wang, et al.
Journal of the American College of Cardiology
|
July 8, 2026
Cardiovascular Health Change Patterns After Multifaceted Antihypertensive Intervention and Cardiovascular Outcomes: A Post Hoc Analysis of CRHCP Trial
Xiaofan Guo, Guozhe Sun, Ziyi Xie, et al.
Lancet (London, England)
|
March 5, 2023
Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial
Jiang He, Nanxiang Ouyang, Xiaofan Guo, et al.
Scientific Reports
|
May 19, 2016
VEGF-B inhibits hyperglycemia- and Macugen-induced retinal apoptosis
Delong Huang, Chen Zhao, Rong Ju, et al.
BMC Medicine
|
March 3, 2026
Cardiovascular outcomes of intensive blood pressure control in patients with and without metabolic dysfunction-associated fatty liver disease: post hoc analysis of the CRHCP trial
Songyue Liu, Yangzhi Yin, Hongmei Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 20, 2017
Critical role of caveolin-1 in ocular neovascularization and multitargeted antiangiogenic effects of cavtratin via JNK
Yida Jiang, Xianchai Lin, Zhongshu Tang, et al.
Oncotarget
|
October 28, 2016
PDGF-CC underlies resistance to VEGF-A inhibition and combinatorial targeting of both suppresses pathological angiogenesis more efficiently
Lei Zheng, Chen Zhao, Yuxiang Du, et al.
Signal Transduction and Targeted Therapy
|
August 17, 2023
VEGF-B prevents excessive angiogenesis by inhibiting FGF2/FGFR1 pathway
Chunsik Lee, Rongyuan Chen, Guangli Sun, et al.
Page
of 7